Excellence in cardiometabolic clinical trials: Two Phase Ib/2a case studies
By Nucleus Network
Watch this new, on-demand webinar to discover the secrets to delivering the data required to move cardiometabolic assets from Phase 1 to 2.
Delivered by Dr Graham Wood, Chief Scientific Officer, and Dr Trisha Shamp, VP Medical Operations and US Principal Investigator at Nucleus Network, the webinar examines two recently completed Phase 2 cardiometabolic studies, exploring how AI-driven digital recruitment strategies can be applied to overcome high screen failure rates in MASLD and obesity studies, and how clinical trial operators can design participant engagement workflows that sustain compliance above 96% and retention above 94%.
Download now below.